Free Trial
OTCMKTS:BCYP

Big Cypress Acquisition (BCYP) Stock Price, News & Analysis

Big Cypress Acquisition logo
$8.44 -2.01 (-19.23%)
As of 10/22/2021

About Big Cypress Acquisition Stock (OTCMKTS:BCYP)

Key Stats

Today's Range
$8.21
$12.90
50-Day Range
$8.44
$8.44
52-Week Range
$8.21
$12.90
Volume
15.34 million shs
Average Volume
160,982 shs
Market Capitalization
$124.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BCYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCYP Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Solar Stock Losers in Sharp's Big U.S. Acquisition
Big Ass Fans
SAB Biotherapeutics Inc
See More Headlines

BCYP Stock Analysis - Frequently Asked Questions

Big Cypress Acquisition's stock was trading at $8.44 on January 1st, 2025. Since then, BCYP shares have increased by 0.0% and is now trading at $8.44.

Big Cypress Acquisition Corp. (OTCMKTS:BCYP) announced its quarterly earnings data on Tuesday, November, 11th. The technology company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to analyst estimates of $0.21 million.

Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Big Cypress Acquisition investors own include FuelCell Energy (FCEL), Onconova Therapeutics (ONTX), Co-Diagnostics (CODX), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Last Earnings
11/11/2014
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:BCYP
CIK
1399587
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.13
Quick Ratio
6.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
14,792,000
Free Float
N/A
Market Cap
$124.84 million
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:BCYP) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners